The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Novartis Bioventures Ltd since year 2005.
The trader's CIK number is 1297709.
At the time of this reporting, Novartis Bioventures Ltd is the 10% Owner of Akebia Therapeutics, Inc. .
(stock ticker symbol AKBA).
See this page for all insider trading activities at Akebia Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-03-25||AKBA||Akebia Therapeutics, Inc.||Buy||182,590||17.00||3,104,030|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Novartis Bioventures Ltd (10% Owner of Akebia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.